- Home
- AXDX vs XCUR Comparison
AXDX vs XCUR Comparison
Compare AXDX & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- XCUR
- Stock Information
- Founded
- AXDX 1982
- XCUR 2011
- Country
- AXDX United States
- XCUR United States
- Employees
- AXDX N/A
- XCUR N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- AXDX Industrials
- XCUR Health Care
- Exchange
- AXDX Nasdaq
- XCUR Nasdaq
- Market Cap
- AXDX 41.8M
- XCUR 39.9M
- IPO Year
- AXDX 1996
- XCUR N/A
- Fundamental
- Price
- AXDX $1.20
- XCUR $17.56
- Analyst Decision
- AXDX Hold
- XCUR
- Analyst Count
- AXDX 1
- XCUR 0
- Target Price
- AXDX $1.00
- XCUR N/A
- AVG Volume (30 Days)
- AXDX 63.7K
- XCUR 1.7M
- Earning Date
- AXDX 11-07-2024
- XCUR 11-14-2024
- Dividend Yield
- AXDX N/A
- XCUR N/A
- EPS Growth
- AXDX N/A
- XCUR N/A
- EPS
- AXDX N/A
- XCUR N/A
- Revenue
- AXDX $11,909,000.00
- XCUR $500,000.00
- Revenue This Year
- AXDX $1.50
- XCUR N/A
- Revenue Next Year
- AXDX $4.17
- XCUR N/A
- P/E Ratio
- AXDX N/A
- XCUR N/A
- Revenue Growth
- AXDX N/A
- XCUR N/A
- 52 Week Low
- AXDX $0.73
- XCUR $1.44
- 52 Week High
- AXDX $4.68
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- AXDX 28.60
- XCUR 52.41
- Support Level
- AXDX $1.32
- XCUR $17.12
- Resistance Level
- AXDX $1.42
- XCUR $19.22
- Average True Range (ATR)
- AXDX 0.12
- XCUR 4.39
- MACD
- AXDX -0.04
- XCUR -1.09
- Stochastic Oscillator
- AXDX 10.53
- XCUR 20.37
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.